New immunotherapy shows promise in fighting resistant pancreatic cancer
Labiotech - 04-May-2023IMAN therapy targets tumours and activates the immune system against tough-to-treat cancers
Labiotech
News provider covering the European biotech innovation
Labiotech.eu is the leading online media for the biotech industry in Europe. Our team of experienced journalists produces daily analyses and insights so you can stay up to date and well informed.
Labiotech.eu was founded in 2014 by two biotech engineers in response to the lack of digital media covering the European biotechnology industry. Over the years, the website grew to become the most visited biotech website in Europe and a trusted source of information for many professionals.
The mission of Labiotech.eu is to provide the biotech community with current and relevant information about the life sciences industry.
Visit website: https://labiotech.eu/
Details last updated 04-Feb-2019
Labiotech Creations
Can RNA drugs solve the obesity epidemic?
Podcast from Labiotech-Resalis Therapeutics is pioneering an innovative approach to obesity treatment
Anocca’s VIDAR-1: Revolutionizing pancreatic cancer with TCR-T cell therapy
Podcast from Labiotech- Anocca Pioneers Pancreatic Cancer Care with VIDAR-1 TCR-T Cell Therapy
Visugromab: The revolutionary monoclonal antibody conquering solid tumor resistance
Podcast from Labiotech- Visugromab: A New Frontier in Beating Resistance in Solid Tumors
Meeting the global demand for cell therapies: scaling with smart manufacturing
Podcast from Labiotech-Scaling Cell Therapies to Meet Global Demand Through Smart Manufacturing
Mitochondrial therapeutics: The future of aging and neurodegenerative disease?
Podcast from Labiotech - The Promise of Mitochondrial Medicine in Tackling Ageing and Neurodegeneration
Targeting telomerase to disrupt cancer
Podcast from Labiotech- Telomerase Inhibition as a Therapeutic Strategy in Cancer
How generative AI and ’Photoshop for proteins’ are transforming biopharma R&D
Podcast from Labiotech-Elise de Reus explores how their platform is putting tech into biotech
Harnessing the body’s natural targeted protein degradation system to treat diseases
Podcast from Labiotech-Leveraging the body's protein degradation system to treat disease
Estonia’s biobank: Is this the first large-scale personalized medicine initiative?
Podcast from Labiotech-Estonia’s biobank: A pioneer in large-scale personalized medicine?
Targeting inflammation: A revolution in disease treatment
Podcast from Labiotech- Targeting inflammation: Transforming disease treatment
New German biotech spins out to develop radiotherapeutics
Podcast from Labiotech- German biotech launches to develop radiotherapy-based treatments
Cutting through the AI hype in drug discovery
Podcast from Labiotech- LabGenius: Cutting through AI hype in drug development
Persica Pharmaceuticals is treating the cause of chronic lower back pain, not just the symptoms
Podcast from Labiotech- Persica targets the root cause of chronic back pain
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech
Podcast from Labiotech- Alex Telford on AI, digital twins, and biotech’s biggest questions
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Podcast from Labiotech- Lab-grown blood vessels saving lives in war zones
People at Labiotech
Articles sourced from Labiotech
Mogrify and Astellas collaborate on novel gene therapy for hearing loss
Labiotech - 17-Nov-2022Breakthrough approach to regenerate new cochlear hair cells that enable hearing
Breakthrough cell therapy shows promise in treating multiple solid tumours
Labiotech - 14-Sep-2022LIfT Biosciences' N-LIfT therapy targets and destroys tumours with a unique immune-based approach
BioAge and Age Labs partner to advance healthy ageing research
Labiotech - 24-Aug-2022They aim to identify aging pathways and develop new drugs and biomarkers
EA-2353, a photoreceptor regeneration treatment for blindness, by Endogena Therapeutics
Labiotech - 12-Jul-2022Endogena's gene-independent treatment has shown advantages in retinitis pigmentosa
AgomAb raises €62M in Series B round to advance regenerative medicine
Labiotech - 16-Mar-2021Funds to bring the experimental drug to trials; symbolizes booming regenerative niche
HepaRegeniX raised €11M to fund clinical trials for a drug that regenerates liver
Labiotech - 21-Jan-2021This treatment could help in cases of severe liver disease, like NASH
Labiotech gathers feedback from European biotechs on Unity failure
Labiotech - 28-Aug-2020General feeling that failures are bound to happen - but that their approaches can succeed
LabGenius raises €8.9M to advance its AI and robotics-based drug discovery
Labiotech - 24-Oct-2019Their "robot scientist" EVA is set to transform protein-based therapeutics
State of play of single-cell sequencing technology
Labiotech - 14-Oct-2019Extreme personalised medicine realises there is no such thing as an average cell
Mini Brains Grown in a Dish
Labiotech - 25-Jul-2018These small organoids are being used to study Glioblastoma (brain cancer) safely
Immunethep seeks funding to take its novel bacteria vaccine into clinical trials
Labiotech - 09-Mar-2018Alexander Burik sensibly advises caution about any new type of treatment
Why You Should Avoid Eating too Much Junk Food
Labiotech - 15-Jan-2018Unhealthy diets may trigger immune activation, worsening diabetes and arteriosclerosis
Gene Therapy Trial to Restore Sight in Retinitis Pigmentosa
Labiotech - 10-Jan-2018GenSight using gene therapy and a wearable device to restore sight in patients with retinitis pig...
Nanoparticles heat up to kill cancer cells
Labiotech - 25-Oct-2017Thermotherapy is limited by the damage it causes to healthy tissues. At 42-45°C cancer cells can...
Bionic Implant to Restore Vision Enters Clinical Trials
Labiotech - 20-Oct-2017Pixium Vision has received approval in France to start a clinical trial. PRIMA is a miniature wi...
Interview with PCR Workflow Automation Company CEO
Labiotech - 02-Oct-2017Wouter Uten recognized a need in the diagnostic industry for more automated laboratory workflows....
Stem cell tourism may end your life
Labiotech - 08-Sep-2016Desperate patients are ready to do everything to access to new treatments. Easily misled by head...
Biotech secures €60M for DNA Synthesis
Labiotech - 27-Jan-2016Proprietary synthetic DNA manufacturing process from Twist Bioscience features a 10,000-well sili...
10 Hot European Biotechs to watch in 2016
Labiotech - 12-Jan-2016Including immuno-oncology treatments, antibody delivery, Tau-aggregation inhibitors and mRNA ther...
Display all articles
